your badges 52W Range $73–$199 69% of range Analyst Rating BUY 14 analysts Price Target $229 +43% upside P/E -69.1 ROE -16.9% Net Profit Margin ·

BLTE Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $159.56
Market Cap $6.28B
P/E -69.1
EPS $-2.31
ROE -16.9%
52W Range $73–$199

BLTE Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
EPS$-2.31
2020-12-31 → 2025-12-31
Free Cash Flow$-37M
2022-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend BLTE 5Y avg Peer Median Verdict
P/E -69.15Y avg ≈-52.3 ≈-52.3 · ·
P/B 8.15Y avg ≈13.7 ≈13.7 7.5 Fair value
Price / FCF -169.45Y avg ≈-86.5 ≈-86.5 · ·
Price / Cash Flow -169.75Y avg ≈-87.3 ≈-87.3 · ·
Price / Tangible Book 8.15Y avg ≈13.7 ≈13.7 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -14.0%
Next Report Nov 09, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 13, 2026 $-0.70 $-0.80 13.0%
March 31, 2026 May 20, 2026 $-0.68 $-0.65 -4.9%
Dec. 31, 2025 $-0.70 $-0.56 -25.6%
Sept. 30, 2025 $-0.65 $-0.50 -30.7%
June 30, 2025 $-0.50 $-0.43 -17.4%
March 31, 2025 $-0.45 $-0.38 -18.1%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 15
Metric Trend 20252024202320222021
R&D Expense $45M$30M$25M$9M$7M
SG&A Expense $39M$10M$7M$4M$2M
Operating Expenses $84M$40M$32M$13M$10M
Operating Income $-84M$-40M$-32M$-13M$-10M
Interest Expense ··$25.0K$16.0K·
Interest Income $7M$4M$74.0K$23.0K$5.0K
Other Non-op $-41.0K$141.0K$-4.0K$166.0K$126.0K
Pretax Income $-78M$-36M$-32M$-13M$-10M
Income Tax $0$6.0K$9.0K··
Net Income $-78M$-36M$-32M$-13M$-10M
EPS (Basic) $-2.31$-1.18$-1.19$-0.63$-1.01
EPS (Diluted) $-2.31$-1.18$-1.19$-0.63$-1.01
Shares (Basic) 33,538,16030,538,37826,593,67319,976,5969,569,932
Shares (Diluted) 33,538,16030,538,37826,593,67319,976,5969,569,932
EBITDA $-84M$-40M$-32M$-13M·
Balance Sheet 19
Metric Trend 20252024202320222021
Cash & Equivalents $353M$32M$88M$42M$17M
Prepaid Expense $1M$1M$947.0K$716.0K$87.0K
Other Current Assets $5.0K····
Current Assets $494M$147M$90M$43M$17M
PP&E (Net) $344.0K$444.0K$490.0K$541.0K$94.0K
Accum. Depreciation $507.0K$341.0K$183.0K$91.0K$47.0K
Intangibles $19.0K$31.0K···
Total Assets $781M$152M$95M$44M$18M
Accrued Liabilities $10M$6M$3M$2M$2M
Current Liabilities $10M$6M$4M$2M$2M
Capital Leases $188.0K$261.0K$578.0K$668.0K·
Total Liabilities $10M$6M$4M$3M$2M
Common Stock $4.0K$3.0K$3.0K$3.0K$1.0K
Paid-in Capital $956M$254M$162M$82M$12M
Retained Earnings $-185M$-108M$-72M$-40M$-27M
AOCI $-536.0K$-660.0K$-374.0K$-392.0K$-196.0K
Stockholders' Equity $770M$146M$90M$42M$-15M
Liabilities + Equity $781M$152M$95M$44M$18M
Shares Outstanding 39,339,96031,826,54929,149,44424,898,90810,274,403
Cash Flow 10
Metric Trend 20252024202320222021
Stock-based Comp $39M$9M$4M$1M$2M
Amort. of Intangibles $12.0K$4.0K···
Operating Cash Flow $-37M$-29M$-30M$-11M$-7M
CapEx $71.0K$116.0K$63.0K$394.0K$74.0K
Investing Cash Flow $-305M$-111M$-63.0K$-394.0K$-56.0K
Financing Cash Flow $663M$84M$76M$37M$-583.0K
Net Change in Cash $321M$-56M$46M$25M$-8M
Taxes Paid ·$6.0K$9.0K··
Free Cash Flow $-37M$-29M$-30M$-12M·
Levered FCF ··$-30M··
Profitability 3
Metric Trend 20252024202320222021
ROA -16.6%-29.3%-45.5%-40.4%·
ROE -16.9%-30.6%-47.9%-95.8%·
ROIC -10.9%-27.4%-35.0%··
Liquidity & Solvency 3
Metric Trend 20252024202320222021
Current Ratio 50.024.324.820.3·
Quick Ratio 35.75.224.320.0·
Interest Coverage ··-1266.7-801.3·
Per Share 4
Metric Trend 20252024202320222021
Book Value / Share $19.59$4.58$3.10$1.67·
Cash Flow / Share $-1.10$-0.96$-1.12$-0.57·
Cash / Share $8.97$1.00$3.02$1.69·
EPS (TTM) $-2.31$-1.18$-1.19$-0.63·
Valuation (TTM) 8
Metric Trend 20252024202320222021
Net Income TTM $-78M$-36M$-32M$-13M·
Market Cap $6.29B$2.01B$1.33B$751M·
P/E -69.2-53.5-38.4-47.8·
P/B 8.213.814.718.1·
P / Tangible Book 8.213.814.718.1·
P / Cash Flow -170.1-68.7-44.7-65.5·
P / FCF -169.8-68.4-44.6-63.3·
Earnings Yield -1.4%-1.9%-2.6%-2.1%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Net Income $-78M $-36M $-32M $-13M $-10M
Diluted EPS $-2.31 $-1.18 $-1.19 $-0.63 $-1.01

Institutional owners (13F) 82 filers · $1.4B total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 82
Value held $1.4B
New positions 22
Exited positions 14
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
22 (-5 vs prior Q) 14 (-8 vs prior Q) 27 (+2 vs prior Q) 22 (+8 vs prior Q) +372K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Darwin Global Management, Ltd. $456,588,244 3,077,219 32.41% Shares
Paradigm Biocapital Advisors LP $189,844,565 1,232,877 13.48% Shares
RTW INVESTMENTS, LP $110,150,398 715,332 7.82% Shares
MILLENNIUM MANAGEMENT LLC $76,155,438 494,564 5.41% Shares
MAVERICK CAPITAL LTD $61,025,949 396,311 4.33% Shares
EVENTIDE ASSET MANAGEMENT, LLC $60,181,804 390,829 4.27% Shares
DEERFIELD MANAGEMENT COMPANY, L.P. $55,003,288 357,199 3.90% Shares
Holocene Advisors, LP $38,655,624 251,035 2.74% Shares
Logos Global Management LP $38,496,250 250,000 2.73% Shares
MORGAN STANLEY $36,197,407 235,071 2.57% Shares
UBS Group AG $34,644,931 224,989 2.46% Shares
CITADEL ADVISORS LLC $28,667,080 186,168 2.03% Shares
GOLDMAN SACHS GROUP INC $25,590,459 166,188 1.82% Shares
Affinity Asset Advisors, LLC $25,407,525 165,000 1.80% Shares
MPM BIOIMPACT LLC $21,127,974 137,208 1.50% Shares
BANK OF AMERICA CORP /DE/ $19,214,710 124,783 1.36% Shares
Patient Square Capital LP $16,938,350 110,000 1.20% Shares
JANE STREET GROUP, LLC $10,132,367 65,801 0.72% Shares
BNP PARIBAS FINANCIAL MARKETS $8,796,393 57,125 0.62% Shares
RENAISSANCE TECHNOLOGIES LLC $8,586,666 55,763 0.61% Shares
Point72 Asset Management, L.P. $7,881,877 51,186 0.56% Shares
Soleus Capital Management, L.P. $7,779,938 50,524 0.55% Shares
Trexquant Investment LP $7,624,721 49,516 0.54% Shares
TWO SIGMA INVESTMENTS, LP $5,866,829 38,100 0.42% Shares
PFM Health Sciences, LP $5,359,140 34,803 0.38% Shares
JPMORGAN CHASE & CO $5,131,442 33,181 0.36% Shares
Walleye Capital LLC $4,884,558 31,721 0.35% Shares
Artia Global Partners LP $3,847,931 24,989 0.27% Shares
GEODE CAPITAL MANAGEMENT, LLC $3,486,220 22,640 0.25% Shares
BALANCE CAPITAL PARTNERS L.P. $3,464,663 22,500 0.25% Shares
NATIONAL BANK OF CANADA /FI/ $3,079,700 20,000 0.22% Shares
STATE STREET CORP $2,452,057 15,924 0.17% Shares
Verdad Advisers, LP $2,118,526 13,758 0.15% Shares
ORBIMED ADVISORS LLC $2,048,001 13,300 0.15% Shares
TD Asset Management Inc $2,003,345 13,010 0.14% Shares
BOOTHBAY FUND MANAGEMENT, LLC $1,960,691 12,733 0.14% Shares
Qube Research & Technologies Ltd $1,874,151 12,171 0.13% Shares
Lighthouse Investment Partners, LLC $1,539,850 10,000 0.11% Shares
MANUFACTURERS LIFE INSURANCE COMPANY, THE $1,512,133 9,820 0.11% Shares
HighVista Strategies LLC $1,471,173 9,554 0.10% Shares
Squarepoint Ops LLC $1,352,758 8,785 0.10% Shares
BARCLAYS PLC $1,050,486 6,822 0.07% Shares
Capricorn Fund Managers Ltd $985,504 6,400 0.07% Shares
Voleon Capital Management LP $968,412 6,289 0.07% Shares
SmartHarvest Portfolios, LLC $671,221 4,359 0.05% Shares
XTX Topco Ltd $667,217 4,333 0.05% Shares
Mariner, LLC $590,533 3,835 0.04% Shares
Entropy Technologies, LP $569,745 3,700 0.04% Shares
High Net Worth Advisory Group LLC $538,948 3,500 0.04% Shares
FMR LLC $477,354 3,100 0.03% Shares

Show all 82 institutional owners →

Company insiders 5 insiders · 4 officers · 3 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Yu-Hsin Lin Chief Executive Officer Sept. 8, 2026 S 70,134 0 25 $-20,817,711
Hao-Yuan Chuang Chief Financial Officer Sept. 8, 2026 S 26,038 0 25 $-13,994,952
Hendrik Peter Scholl Chief Medical Officer June 18, 2026 S 15,000 0 13 $-2,858,130
Nathan L. Mata Chief Scientific Officer May 7, 2026 S 0 0 103 $-2,673,521
Wan-Shan Chen Director April 9, 2026 S 9,096 0 1 $-198,473

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 1 ETF

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
BBC · ETFis Series Trust I 0.77% 2,250 NS July 31, 2026 N-PORT

BLTE Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 14 analysts BUY
Median target $217.00 +36.0%
4 28.6% Strong Buy
9 64.3% Buy
1 7.1% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

9 analysts · 2026-10-03

Mean target $228.89 +43.5%

← Below all targets Current price $159.56
Low$185.00 Mean$228.89 High$303.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
BLTE $6.29B -69.2 · · -16.9% ·
CORT $3.69B 42.4 12.8% 13.1% 15.5% ·
ELAN $11.25B -48.1 6.2% -4.9% -3.5% 55.0%
AXSM $9.29B -49.6 65.5% -28.7% -227.0% ·
AMRX · 57.3 8.1% 2.4% -80.0% 36.9%
LGND $3.74B 30.8 60.4% 46.4% 13.5% ·
DFTX $1.32B -6.5 212.0% · -71.0% ·
MANE · · · · 82.6% ·
EWTX $2.64B -15.2 · · -30.2% ·
LLY · 46.8 44.7% 31.7% 101.2% ·

Latest News Recent headlines mentioning this company

23
Belite Bio Enters Oversold Territory (BLTE) Nasdaq · 4 months, 1 week ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 20-F filed Mar 31, 2026